WHO Classification of Tumours Editorial Board. Female Genital Tumours. Lyon: IARC Press; 2020.
[2]
Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10-17.
[3]
Emons G, Beckmann MW, Schmidt D, et al. New WHO Classification of Endometrial Hyperplasia. Geburtshilfe Frauenheilkd. 2015;75(2):135-136.
[4]
Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106(4):812-819.
[5]
Mutter GL, Zaino RJ, Baak JP, et al. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol. 2003;22(4):327-334.
[6]
Lurain JR. Uterine cancer. In: Berek JS, Novak E, editors. Berek & Novak's Gynecology. 15th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.
[7]
American College of Obstetricians and Gynecologists. Management of Endometrial Intraepithelial Neoplasia. ACOG Committee Opinion No. 769. Obstet Gynecol. 2019;133(3):e179-e185.
[8]
Galaal K, Al Mogy A, Das N, et al. Risk factors and outcome of atypical endometrial hyperplasia. J Obstet Gynaecol. 2018;38(4):494-499.
[9]
Rakowski JA, Ahmad S, DeSimone CP, et al. Predictors of regression of atypical endometrial hyperplasia. Int J Gynecol Cancer. 2013;23(7):1334-1338.
[10]
Wheeler DT, Bristow RE, Kurman RJ. Histologic features in the female genital tract that may be misinterpreted as malignant. Adv Anat Pathol. 2007;14(5):331-356.